Posted on Feb. 23: McMaster researcher on new frontier of health care

default-hero-image

[img_inline align=”right” src=”http://padnws01.mcmaster.ca/images/Brash2.jpg” caption=”John Brash”]Telerobotic surgery. Functional implants like heart valves and artificial joints. Computer-assisted minimal access surgery. Tissue engineering and regenerative medicine. As a bridge between engineering and health sciences, bioengineering is the newest innovation in medicine and biotechnology.

With established strengths in engineering and health sciences, McMaster is a leader in incubating cutting-edge bioengineering technologies. As part of the Albert Lager Event Series at McMaster University, John Brash, of the Department of Chemical Engineering, will look at how McMaster researchers are working together to link current and emerging areas of molecular, medical, and bioengineering research.

Scientific and technological advances, as well as ongoing debates about Canada's national health care system, have spurred the development of these technologies. In the future, advances in bioengineering will revolutionize health care.

The lecture will take place Tuesday, Feb. 24 from 7 to 8:30 p.m. in Gilmour Hall, Council Chambers, Rm. 111. Admission is $5 per person and includes light refreshments.

The Albert Lager series of educational lectures and events is named after McMaster graduate Albert Abrum Lager. Lager, a great believer in the value of life-long education, was a member of the University Senate and a volunteer on the McMaster Alumni Association Board of Directors. After his death in 1992, his estate created the Albert Abrum Lager Foundation and this foundation supports a group of organizations whose work Lager valued, including the McMaster Alumni Association.